𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vaccination against hepatitis B — The current situation

✍ Scribed by W. Jilg; F. Deinhardt


Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
273 KB
Volume
14
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Successful postexposure vaccination agai
✍ Dr. Sten Iwarson; Martin Wahl; Eva Ruttimann; Philip Snoy; Belinda Seto; Dr. Rob 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

To study the effect of postexposure vaccination, four chimpanzees were vaccinated with hepatitis B (HB) vaccine 4, 8, 48, and 72 hr, respectively, after intravenous injection of an infectious hepatitis B virus (HBV) inoculum. The second and third vaccine inoculations were given 2 and 6 weeks later,

Hepatitis B control in Europe by univers
✍ Pierre Van Damme; Alex Vorsters 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract In the nine years since the Global Advisory Group of the Expanded Programme on Immunisation (WHO) set 1997 as the target for integrating hepatitis B vaccination into national immunisation programmes worldwide, 129 countries have included hepatitis B vaccine as part of their routine infa

Hepatitis B surface antigen (HBsAg) subt
✍ Dr. Wolfgang Jilg; Corinne Delhoune; Friedrich Deinhardt; Anastasia J. Roumeliot 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

One hundred sixty-three persons immunised against hepatitis B with a vaccine containing HBsAg either of adw or ayw subtype were examined for antibodies against the a, d, and y determinants of HBsAg. Sera were tested for antibodies against HBsAg adw and HBsAg ayw separately by a solid-phase radioimmu

De novo hepatitis B infection after live
✍ Marinho, Rui Tato ;Ramalho, Fernando ;Velosa, José 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 29 KB 👁 1 views

## To the Editors: De novo hepatitis B infection after liver transplantation, in spite of its low prevalence as found by Fabia et al, 1 is of major concern, especially for infected patients and their families. More follow-up time is needed to assess the real impact in morbidity, mortality, and eco

Low-dose vaccination against hepatitis B
✍ Mr. Alexander Milne; Mary Dimitrakakis; Carolyn Campbell; Ron Lucas; Geoff Allwo 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

Six hundred forty-three children, negative for markers of hepatitis B virus (HBV) infections, were given three X 2-micrograms doses of Merck, Sharp and Dohme (MSD) plasma derived hepatitis B vaccine (H-B-Vax) at monthly intervals. Twelve months after the first dose of vaccine, antibody to hepatitis

Efficacy of hepatitis B vaccine against
✍ Saleem Kamili; Vitini Sozzi; Geoff Thompson; Katie Campbell; Christopher M. Walk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Hepatitis B virus (HBV) mutants resistant to treatment with nucleoside or nucleotide analogs and those with the ability to escape from HBV-neutralizing antibody have the potential to infect HBV-vaccinated individuals. To address this potential serious public health challenge, we tested the efficacy